Donor lymphocyte infusions for recurrence of myeloid neoplasms after allogeneic hematopoietic cell transplantation in the era of hypomethylating agents and BCL2 inhibitors

Abstract The combination of hypomethylating agents (HMA) and venetoclax (VEN) has transformed acute myeloid leukemia (AML) treatment. Data on donor lymphocyte infusion (DLI) with HMA/VEN for relapse after allogeneic hematopoietic cell transplantation (alloHCT) remain limited. We retrospectively anal...

Description complète

Détails bibliographiques

Auteurs principaux:	Miriam Mozaffari Jovein, Thomas Meyer, Miguel Waterhouse, Dietmar Pfeifer, Jesús Duque-Afonso, Michael Lübbert, Kristina Maas-Bauer, Ralph Wäsch, Hartmut Bertz, Justus Duyster, Robert Zeiser, Jürgen Finke, Claudia Wehr
Format:	Artigo
Langue:	Inglês
Publié:	Springer 2026-03-01
Collection:	Annals of Hematology
Sujets:	Allogeneic stem cell transplantation Relapsed AML Myeloid neoplasms Hypomethylating agents Donor lymphocyte infusions Venetoclax
Accès en ligne:	https://doi.org/10.1007/s00277-026-06973-7
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!